ALPS ADVISORS INC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$316,000
+68.1%
36,356
+142.1%
0.00%
+200.0%
Q4 2017$188,000
+72.5%
15,019
+15.1%
0.00%0.0%
Q3 2017$109,000
+808.3%
13,050
+9.1%
0.00%
Q2 2017$12,00011,9590.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 610,045$2,014,0000.47%
ETF MANAGERS GROUP, LLC 1,814,328$5,987,0000.13%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 72,169$238,0000.06%
Bernardo Wealth Planning LLC 27,219$89,0000.03%
Affinity Asset Advisors, LLC 13,285$44,0000.02%
ALGERT GLOBAL LLC 20,778$69,0000.02%
ZEKE CAPITAL ADVISORS, LLC 49,700$164,0000.01%
Founders Capital Management 2,000$18,0000.01%
King Wealth Management Group 16,000$53,0000.01%
Penserra Capital Management LLC 129,252$425,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders